Detection of the mosquito-borne flaviviruses, West Nile, Dengue, Saint Louis Encephalitis, Ilheus, Bussuquara, and Yellow Fever in free-ranging black howlers (Alouatta caraya) of Northeastern Argentina.

Several medically important mosquito-borne flaviviruses have been detected in Argentina in recent years: Dengue (DENV), St. Louis encephalitis (SLEV), West Nile (WNV) and Yellow Fever (YFV) viruses. Evidence of Bussuquara virus (BSQV) and Ilheus virus (ILHV) activity were found, but they have not been associated with human disease. Non-human primates can act as important hosts in the natural cycle of flaviviruses and serological studies can lead to improved understanding of virus circulation dynamics and host susceptibility. From July-August 2010, we conducted serological and molecular surveys in free-ranging black howlers (Alouatta caraya) captured in northeastern Argentina. We used 90% plaque-reduction neutralization tests (PRNT90) to analyze 108 serum samples for antibodies to WNV, SLEV, YFV, DENV (serotypes 1and 3), ILHV, and BSQV. Virus genome detection was performed using generic reverse transcription (RT)-nested PCR to identify flaviviruses in 51 antibody-negative animals. Seventy animals had antibodies for one or more flaviviruses for a total antibody prevalence of 64.8% (70/108). Monotypic (13/70, 19%) and heterotypic (27/70, 39%) patterns were differentiated. Specific neutralizing antibodies against WNV, SLEV, DENV-1, DENV-3, ILHV, and BSQV were found. Unexpectedly, the highest flavivirus antibody prevalence detected was to WNV with 9 (8.33%) monotypic responses. All samples tested by (RT)-nested PCR were negative for viral genome. This is the first detection of WNV-specific antibodies in black howlers from Argentina and the first report in free-ranging non-human primates from Latin-American countries. Given that no animals had specific neutralizing antibodies to YFV, our results suggest that the study population remains susceptible to YFV. Monitoring of these agents should be strengthened to detect the establishment of sylvatic cycles of flaviviruses in America and evaluate risks to wildlife and human health.

Introduction

Emerging and re-emerging diseases are one of the main threats to global public health; 60% of these diseases are zoonoses (diseases shared between humans and vertebrate animals) and the majority originated from wildlife [1]. The increasing incidence of these diseases is related to the intense ecological changes that occur at local, regional, and global scales. Several unexpected emergences of zoonotic flaviviruses worldwide were recently recognized. The introduction of West Nile virus (WNV) and Zika virus (ZIKV) into the New World [2,3] and the emergence of Japanese encephalitis virus in Australia a few prominent examples [4]. Currently there are 39 defined members of the mosquito-borne viruses of the genus Flavivirus [5]. They usually infect a variety of vertebrate and mosquito species. Some flaviviruses have a limited number of hosts and vectors, others replicate in many hosts and vectors. Some have an extremely widespread distribution; others are spatially restricted. The potential of flaviviruses to cause disease in humans is significant and they have a potential to induce losses in livestock or wild animals of economic and ecological importance.

Several of the most prominent and medically important mosquito-borne flaviviruses were detected in Argentina in recent years: Dengue virus (DENV), St. Louis encephalitis virus (SLEV), WNV and Yellow Fever virus (YFV). During 2016, Zika virus was also detected in Argentina with autochthonous circulation restricted to Tucuman Province [6]. Other flaviviruses circulating in Argentina include Bussuquara virus (BSQV) and Ilheus virus (ILHV), which have not yet been associated with human disease [7].

Dengue viruses have emerged as the most important human arboviral pathogens from non-human primate enzootic reservoirs to humans resulting in an urban endemic transmission cycle. In Africa and Southeast Asia the viruses have been maintained in a sylvatic cycle, most likely involving non-human primates as reservoirs. These cycles have not been recognized in South America, but serological studies have suggested a possible secondary amplification cycle involving mammals other than non-human primates. The question of whether mammals maintain DENV in enzootic cycles and can play a role in its reemergence in human populations remains to be answered [8, 9]. Argentina was free of dengue for more than 80 years before the disease was detected in 1998. However, in the last 18 years, indigenous DENV circulation has been reported in Northern and Central Argentina, representing a growing public health problem [6, 10, 11].

Since 2002 Argentina has experience the re-emergence of SLEV, with febrile illness and encephalitis outbreaks in humans, mainly in temperate areas of the country [12-14]. Genotypes II, III, V, and VII of SLEV were detected in mosquitoes and rodents [15, 16]. High SLEV antibody prevalence was demonstrated in black howlers in Argentina and southern Brazil but the role that primates could play in viral maintenance in nature is unknown [17, 18].

The isolation of WNV from equines in Argentina in 2006 was the first direct evidence of its circulation in the Southern Cone. Nucleotide sequences showed that the virus belonged to clade 1a of lineage 1 and clustered in a subclade with American strains isolated during 1999–2002 [19, 20]. Public health surveillance in Argentina detected sporadic human cases in 2006–2007 in five provinces of the northeast and central areas of the country(Chaco, Entre Ríos, Formosa, Santa Fé, and Córdoba Provinces) but the impact on animal and human public health was considerably lower than in the northern hemisphere until now [21, 22]. Detection of WNV in resident birds in 2005–2006 suggested that it was introduced into Argentina and maintained naturally in enzootic foci where numerous bird species from many families were exposed [23]. The transmission cycle of WNV commonly involves birds and Culex mosquitoes, but it is not well known in Argentina. Recent studies of vector competence showed that Argentine Culex are competent vectors, but they were characterized as moderately efficient vectors of WNV and less susceptible to infection than US mosquito strains [24].

Yellow fever is an infectious disease that remains endemic or enzootic in rainforests of South America and sub-Saharan Africa. The sylvatic yellow fever cycle is maintained by viral circulation between monkeys and diurnally active mosquitoes that breed in tree holes in the forest canopy. Many species of non-human primates are hosts of this cycle. The species most commonly involved in virus transmission are New World monkeys of the genera Cebus, Alouatta, and Callithrix. The susceptibility of monkeys to lethal infections of YFV in America has been considered a major indicator for enzootic disease outbreaks in forest areas [25-27]. Sylvatic cases of yellow fever in humans were often preceded by epizootics in animals in Brazil and Argentina [28, 29]. Black howlers inhabit the Chaco and Pantanal ecoregions in Brazil, Paraguay, Bolivia, and north-northeastern Argentina, a small portion of the Atlantic Forest in Misiones Province, Argentina, and the state of Rio Grande do Sul, Brazil [30-32]. Epizootics were reported in Argentina during 2007–2009 in Misiones and Corrientes Provinces where four native species of monkeys live, including the black howler (Alouatta caraya) [33, 34]. This species has the southernmost distribution of all primate species in the Neotropics, reaching latitude 29°S. In Argentina, black howlers inhabit a complex forest consisting of humid Chaco forest, savannas, gallery forest, and flooded forest (Chaco, Formosa, Corrientes, and Santa Fe provinces). Their populations in the upper Paraná Atlantic Forest are fragile and recurrence of YFV circulation or other pathogens could be harmful to the species maintenance [35, 36].

Viruses and viral disease outbreaks play an ecological role increasingly recognized in populations of wild animals. At least 27 viruses have been reported to infect both humans and wild primates and most of them are classified as emerging threats to human populations [37, 38]. The rapid expansion of human activities into habitats of primates has resulted in increased potential for exchange of pathogens, creating challenges for biodiversity conservation and global health. The role of many wildlife species as reservoirs for arthropod-borne viral pathogens is poorly understood. Virus-specific antibody detection in a wildlife species could indicate a reservoir host or a species that could serve as a sentinel for virus activity in nature.

Due to the impact of recent yellow-fever epidemics, there was special concern about the status of the black howler, which is the monkey species most affected by epizootics in Argentina. We conducted serological and molecular tests to detect flavivirus circulation in free-living black howlers in Northeast Argentina in 2010.

Materials and methods

Study sites

The study was carried out in July–August 2010 in San Cayetano (SC), Corrientes province (27 ° 34 'S, 58 ° 41' W); Isla del Cerrito (IC) (27° 17´S, 58° 37´W), and Isla Brasilera (IB), Chaco province (27 ° 20 'S, 58 ° 40' W) in northeastern Argentina (Fig 1). San Cayetano is a savanna with degraded and fragmented semi-deciduous forest. Forest fragments have been modified by deforestation, cattle introduction, the reuse of land for plantations, and burning trees allowing humans and monkeys to live in close association [39]. Isla del Cerrito and Isla Brasilera are at the confluence of the Paraguay and Paraná Rivers and are characterized by continuous flooded forest. Sites were classified following two criteria: areas where primate habitat overlapping human populations and agricultural activities (SC and IC) and wild areas where human contact is rare (IB).

Fig 1

Study sites in Chaco and Corrientes provinces, Northeastern Argentina.

Sample collection

Captured black howlers were immobilized with methomidine hydrochloride combined with ketamine hydrochloride, administered via a dart driven by compressed air. To maintain body temperature at optimum conditions, animals were covered with blankets and warm water bottles were placed with them throughout the procedure. From 109 captured black howlers, we collected 108 blood samples. Distribution by provinces was 51 (51.5%) captures in Chaco and 58(48.5%) in Corrientes. Sex, weight, and measurements were recorded [40]. Of the animals studied, 43 (39.8%) were female and 65 (60.2%) were male; 85% were adults and the rest were immature. Blood samples were obtained by puncture of the femoral vein. After evaluation of their health, each animal was transferred to the exact site of capture and observed until it moved into the habitat. Blood samples were centrifuged for at least 10 min at 2000 x g for serum separation and stored in liquid nitrogen in the field. At the laboratory, samples were frozen at -80°C until tested.

Ethics statement

This research complied with the Code of Best Practices for Field Primatology (International Primatological Society), the guidelines for the ethical treatment of primates (IACUC protocol 09267) and the laws of Argentina (through Dirección de Recursos Naturales, Provincia de Corrientes and Dirección de Fauna, Provincia de Chaco, plus approval of the National Institute of Human Viral Diseases, Dr. Julio I. Maiztegui, Ethics Committee for Biomedical Research. The animal capture and identification techniques were designed to be less invasive to preserve the welfare of the animals and relieve potential stress.

Plaque-reduction neutralization tests (PRNT)

Serum samples were heat inactivated at 56°C for 30 min. Two-fold serial dilutions from 1:10 to 1:2560 of each sample were incubated with 100 plaque-forming units (PFU) of WNV (strain ChimeriVax TM WNV), SLEV (strain ChimeriVax TM SLEV), DENV-1 (strain Hawaii), DEN-3 (strain H87), YFV (vaccine strain 17D-YEL), ILHV (Original) and BSQV [41]. Vital dye neutral red was used at 5% for plaque visualization. Plaques were counted and titers were calculated and expressed as the reciprocal of the serum dilution yielding a ≥90% reduction in PFU on Vero cells (PRNT90). Titers ≥10 were considered positive. Monotypic or heterotypic patterns were differentiated according to whether the animal was positive to one or several flaviviruses, respectively. In heterotypic patterns, interpretation of PRNT data was as follows: animals with a neutralizing antibody titer (PRNT90) ≥ four-fold higher than the other flavivirus titers were considered positive for antibody to that virus.

Animals with neutralizing antibody titers against multiple viruses without four-fold difference in titer were considered flavivirus antibody positive with no specific virus identified and labeled as “undetermined” flavivirus.

Viral genome detection

The molecular approach was performed on sera from 27 animals that were PRNT90 antibody negative for all the flaviviruses in our panel and 24 animals that were YFV antibody negative. Viral RNA was extracted from 140 uL of serum using QIAamp viral RNA extraction kit (Qiagen, Inc., Valencia, California, USA) and then generic reverse transcription (RT)-nested PCR was used to identify flaviviruses. This procedure was used to amplify a specific 143-bp fragment of the NS5 gene [42]. The amplified products were visualized by ethidium bromide staining after electrophoresis on a 2.0% high-resolution agarose gel.

Results

Of the 108 black howlers studied, 64.8% (70/108) had evidence of past flavivirus infection. Monotypic (13/70, 19%) and heterotypic (27/70, 39%) patterns were differentiated. The remaining 42% of antibody-positive animals was classified as undetermined for virus identification.

We identified specific neutralizing antibodies against WNV, SLEV, DENV-1, DENV-3, ILHV and BSQV. Antibody prevalences were 22.2% (24/108 with 9 monotypic responses) for WNV, 10.2% (11/108) for SLEV, 1.85% (2/108, 100% monotypic) for DENV (1/108 DENV-3 and 1/108 DENV-1), 0.93% (1/108, monotypic) for ILHV, and 0.93% (1/108, monotypic) for BSQV. Distribution of PRNT90 titers are shown in Table 1 (monotypic pattern) and Table 2 (heterotypic pattern). The WNV antibody titers (and frequency) in antibody-positive animals with monotypic pattern were: 20 (1); 40 (4), 80(3), and 160 (1) (Table 1). The WNV antibody titer distribution in animals with heterotypic pattern was: 40 (6); 80 (2); 160 (2); 320 (4), >1280 (1) (Table 2).

Table 1

Distribution of PRNT90 titers for 7 flaviviruses among 13 positive black howlers with monotypic immune pattern.

Animal identification	PRNT90 Titer							Result Interpretation
	DENV-1	DENV-3	SLEV	WNV	YFV	ILHV	BSQV
PA07001	<10	<10	<10	80	<10	<10	<10	WNV
PA07007	<10	<10	<10	80	<10	<10	<10	WNV
PA07008	<10	<10	<10	80	<10	<10	<10	WNV
PA07021	<10	20	<10	<10	<10	<10	<10	DENV-3
PA07036	<10	<10	<10	40	<10	<10	<10	WNV
PA07075	80	<10	<10	<10	<10	<10	<10	DENV-1
PA07079	<10	<10	<10	40	<10	<10	<10	WNV
PA07082	<10	<10	<10	40	<10	<10	<10	WNV
PA07083	<10	<10	<10	160	<10	<10	<10	WNV
PA07092	<10	<10	<10	40	<10	<10	<10	WNV
PA07099	<10	<10	<10	<10	<10	<10	20	BSQV
PA07103	<10	<10	<10	<10	<10	20	<10	ILHV
PA07108	<10	<10	<10	20	<10	<10	<10	WNV

Table 2

Distribution of PRNT90 titers for 7 flaviviruses among 27 positive black howlers with heterotypic immune pattern.

Animal Identification	PRNT90 Titer							Result Interpretation
	DENV-1	DENV-3	SLEV	WNV	YFV	ILHV	BSQV
PA07019	10	10	160	20	<10	10	<10	SLE V
PA07030	<10	40	<10	320	<10	10	40	WNV
PA07035	<10	<10	40	10	<10	<10	<10	SLEV
PA07039	<10	<10	80	320	<10	10	<10	WNV
PA07040	<10	<10	<10	80	<10	20	10	WNV
PA07043	20	<10	640	10	<10	<10	<10	SLEV
PA07052	80	40	320	80	<20	20	10	SLEV
PA07073	<10	<10	10	40	<10	<10	<10	WNV
PA07076	80	10	320	80	<10	10	10	SLEV
PA07077	40	10	160	20	<10	<10	<10	SLEV
PA07078	10	20	80	<10	<10	<10	<10	SLEV
PA07084	10	10	10	320	<10	10	10	WNV
PA07085	<10	<10	10	40	<10	10	10	WNV
PA07088	<10	<10	10	40	<10	<10	<10	WNV
PA07091	10	20	>1280	20	<10	<10	<10	SLEV
PA07100*	<10	<10	40	160	10	<10	<10	WNV
PA07102	<10	<10	<10	80	<10	20	<10	WNV
PA07104*	20	20	640	160	20	40	20	SLEV
PA07105	<10	<10	10	40	<10	<10	<10	WNV
PA07109	<10	<10	10	40	<10	<10	<10	WNV
PA07112	10	20	40	>1280	<10	>20	10	WNV
PA07113	20	10	20	320	<10	10	10	WNV
PA07117	10	10	80	10	<10	<10	<10	SLEV
PA07118	<10	10	40	10	<10	<10	<10	SLEV
PA07121	10	10	<10	40	<10	<10	<10	WNV
PA07016	<10	<10	<10	160	<20	20	<10	WNV
PA07049	<10	<10	40	<10	<10	10	<10	SLEV

*Black howler with neutralizing antibodies against YFV.

DENV-1, Dengue virus serotype 1; DENV-3, Dengue virus serotype 3; SLEV, Saint Louis encephalitis virus; WNV, West Nile virus; YFV, Yellow fever virus; ILHV, Ilheus virus and BSQV, Bussuquara virus.

There were no statistically significant differences in the prevalences of infection for each flavivirus between sexes or among study sites or habitat classes. When antibody distribution was analyzed by age, a statistical difference was observed only for WNV antibody prevalence in adult black howlers (p = 0.0075).

In 30 of 70 animals (43%) results were inconclusive because of neutralizing antibody titers against multiple viruses without fourfold difference; those were considered positive for an undetermined flavivirus (Table 3). We observed different reactivity among these: 73% (22/30) for WNV, 61% (18/30) for SLEV, 61% (18/30) for ILHV, 53% DENV-3(16/30), 47% (14/30) for DENV-1, 33% (10/30) for BSQV and 7% (2/30) for YFV.

Table 3

Distribution of PRNT90 titers for 7 flaviviruses among 30 black howlers positive for several flaviviruses without four-fold differences (undetermined flavivirus).

Animal Identification	PRNT90 Titer							Undetermined for
	DENV-1	DENV-3	SLEV	WNV	YFV	ILHV	BSQV
PA07011	<10	<10	10	<10	<10	<10	<10	SLEV **
PA07014	<10	<10	640	640	<10	<10	<10	SLEV, WNV
PA07017	<10	<10	<10	<10	<10	10	<10	ILHV**
PA07018	<10	<10	<10	20	<10	40	<10	WNV,ILHV
PA07027	<10	10	<10	<10	<10	<10	<10	DENV-3 **
PA07037	<10	10	<10	10	<10	<10	<10	DENV-3, WNV
PA07038	<10	10	<10	10	<10	20	20	DENV-3,WNV, ILHV
PA07042	<10	<10	<10	10	<10	<10	<10	WNV **
PA07045	<20	<20	160	80	<20	<10	<10	SLEV, WNV
PA07050	20	<10	<10	<10	<10	10	<10	DENV-1,ILHV
PA07054	40	40	<20	<20	<20	<10	<10	DENV-1, DENV-3
PA07055	40	20	<20	<20	<20	<10	<10	DENV-1, DENV-3
PA07072	80	40	1280	1280	20*	80	10	SLEV,WNV, DENV-1,DENV-3,ILHV,BSQV, YFV
PA07074	40	<10	80	40	<10	10	<10	DENV-1, SLEV,WNV,ILHV
PA07080	10	20	160	640	<10	320	20	DENV-1,DENV-3,SLEV,WNV, ILHV, BSQV
PA07081	<10	20	160	320	<10	10	80	DENV-3,SLEV, WNV, ILHV, BSQV
PA07086	10	10	320	640	<10	10	40	DENV-1,DENV-3,SLEV,WNV,ILHV, BSQV
PA07094	10	10	320	320	<10	20	20	DENV-1,DENV-3,SLEV, WNV, ILHV, BSQV
PA07095	<10	<10	10	40	<10	20	10	WNV,SLEV, ILHV, BSQV
PA07097	<10	20	20	40	<10	10	<10	DENV-3, SLEV, WNV, ILHV
PA07101	40	20	<10	20	<10	10	<10	DENV-1,DENV-3, WNV, ILHV
PA07106	20	10	40	40	<10	20	10	DENV-1,DENV-3, SLEV,WNV,ILHV,BSQV
PA07107	10	10	80	40	<10	20	10	DENV-1, DENV-3, SLEV,WNV, ILHV, BSQV
PA07110	10	<10	80	40	10*	40	40	DENV-1, SLEV,WNV, ILHV, BSQV, YFV
PA07111	<10	<10	40	40	<10	10	<10	SLEV, WNV, ILHV
PA07114	<10	<10	<10	10	<10	<10	<10	WNV **
PA07115	10	20	40	<10	<10	10	<10	DENV-1, DENV-3, SLEV, ILHV
PA07116	<10	<10	<10	10	<10	<10	<10	WNV **
PA07119	<10	<10	20	10	<10	<10	<10	SLEV, WNV
PA07120	10	10	<10	<10	<10	<10	<10	DENV-1, DENV-3

*Black howler with neutralizing antibodies against YFV.

** Without 4-fold difference because the lowest dilution studied was 1:10

DENV-1, Dengue virus serotype 1; DENV-3, Dengue virus serotype 3; SLEV, Saint Louis encephalitis virus; WNV, West Nile virus; YFV, Yellow fever virus; ILHV, Ilheus virus and BSQV, Bussuquara virus.

For molecular studies, we selected serum samples from 51 animals. These were 27 animals without flavivirus antibodies and 24 that were YFV antibody negative. All animals analyzed by (RT)–nested PCR were negative for flavivirus genome.

Discussion

Our goal was to understand the potential role of free-living black howlers as hosts in the natural cycles of flaviviruses in Argentina. The PRNT90 used to identify specific antibodies in black howler serum samples indicated a variable prevalence for one or more of six of the seven flaviviruses tested including WNV, SLEV, DENV-1, DENV-3, ILHV, and BSQV. No specific immune response to YFV was detected.

Thirty-four groups of black howlers have been identified in the study area, in about 3,000 ha, several of these groups have been under behavioral study since 2000 [43, 44] in undisturbed forest and in forest fragmented by human activities. These regions provide favorable conditions for the occurrence of outbreaks or for enzootic maintenance of arthropod-borne diseases.

Yellow fever outbreaks occurred near this region in November 2007–October 2008, seriously affecting the populations of two howler monkey species: the brown howler (Alouatta guariba clamitans) and the black howler. In these epizootics, the deaths of 65 monkeys were detected in Misiones and Corrientes provinces [33]. Herein we focused on the prevalence of infection in black howlers with those flaviviruses of recognized public health impact in Argentina (YFV,DENV, SLEV, and WNV). We also included ILHV and BSQV because of their known occurrence in Argentine wildlife.

All flaviviruses are serologically related, which can be demonstrated by binding assays suchas ELISA and by hemagglutination-inhibition tests using polyclonal and monoclonal antibodies. The PRNT90 is one of the most specific test available often used to define several serocomplexes of more closely related flaviviruses. The viral panel was employed to evaluate serological cross-reactions. To increase specificity, we selected a conservative threshold of 90% for PRNT. According with 9thReport of the International Committee of Taxonomy of Viruses [5], WNV and SLEV have been placed together in the Japanese encephalitis group. DENV-1, DENV-2, DENV-3 and DENV-4 compose the dengue virus group. Ilheus virus was included in the Ntaya virus group and BSQV in Aroa virus group. Yellow fever virus is the prototype of the genus Flavivirus and is in its own virus group. Analysis of serological results requires careful evaluation especially when co-circulation of multiple flaviviruses is expected, as in Argentina.

We found different immune patterns in the positive animals: 19% monotypic, 39% heterotypic, and 43% classified as undetermined for viral identification according to our criteria. We included 6 animals in the last group which had only titer of 10 for WNV (3), SLEV (1), DENV-3 (1) and ILHV (1); we couldn´t use 4 fold criteria because the lowest dilution studied was 1:10. When individuals with no previous exposure to a flavivirus are infected with one, a monotypic response to the infecting virus is demonstrated in serological tests, such as PRNT, and the etiologic agent can be accurately identified. Interpretation of heterotypic patterns is complex and 4-fold difference in titers could be a limited criterion to provide distinction of the most recent infection. The antibody response in sequential experimentally infected animals illustrates the difficulty for a serologic diagnosis of WNV infection in animals (or humans) with preexisting flavivirus immunity [45]. Sequential infections with other flavivirus elicit strong cross-reactive anamnestic responses, which may confer immunity, especially within members of the same serogroup [46]. For example, sequential infections SLEV-WNV or WNV-SLEV would present different immune patterns that hinder serological differentiation of each [45]. Monotypic serologic responses were the most reliable as these samples reacted with only one of the 7 viruses employed in the tests. Selection of the virus in the panel is critically important. Future similar studies in Argentina might also include ZIKV.

Prevalence of antibody to WNV antibody was the highest among the flaviviruses evaluated. The monotypic WNV prevalence was 8.33% (9/108) and represents the clearest serologic evidence of WNV activity in a new host in Argentina. We found WNV-positive black howlers at all sampling sites, demonstrating a widespread distribution in the study region.

Higher WNV antibody titers were detected in the group with a heterotypic pattern. This type of response could reflect sequential infections or cross reactions originated by the higher antibody titers. We also detected WNV reactivity in 22 black howlers in the group classified as undetermined flavivirus, thus increasing the WNV antibody prevalence. Because of conservation considerations, we avoided capturing immature individuals or pregnant females. Thus, the higher prevalence in adults may reflect this capture bias. However, we should not rule out the possibility that this result could be due to undetected circulation of WNV in Argentina for some time before its isolation in 2006 [20, 23].

Prevalence of detectable antibody to SLEV in our study was 11% (12/108) without monotypic reaction. This value would be increased if we considered the animals that were SLEV positive among the group classified as “undetermined flavivirus”. Investigations in black howlers from this zone in 2001 confirmed infections with SLEV with prevalences of 35% (by hemagglutination test) and 32% (by PRNT). Studies in 2004–2005 demonstrated SLEV antibody prevalence (12% by hemagglutination test, 2% by mouse neutralization test) in free ranging black howlers in the upper Parana River basin in southern Brazil [17,18]. St. Louis encephalitis virus is endemically established in Argentina and was recognized in several human encephalitis outbreaks in the last decade [12,13, 14]. Our results indicate that SLEV and WNV could have been co-circulating within the region complicating the interpretation of serologic tests.

Only four animals had low neutralizing antibody titers for YFV despite recent epizootics, two of those had specific heterotypic reactions for WNV and SLEV and the others were in the positive group for undetermined flavivirus. These results could represent cross-serologic reaction or past infection. On the other hand, 51 animals were negative for viral genome. We did not detect YFV circulation in black howlers. This small and fragmented population suffers habitat destruction, hunting pressure, and cyclical yellow fever and thus, is at risk of disappearing in the long term [47]. The low antibody prevalence detected suggests that the population remains susceptible to YFV. An interesting aspect would be to know if preexisting antibodies for other flaviviruses could play a protective role in future YFV infections.

We detected monotypic reactions in PRNT90 against DENV-3 (0.93%) and DENV-1 (0.93%). Titers obtained were low but serum samples were previously heat inactivated to eliminate nonspecific reactions. These dengue serotypes were selected because their previous circulation was confirmed in human cases detected in Misiones, Corrientes, and Chaco provinces in 2000–2008. Besides, 47% of the animals were positive to DENV-1 and 53% for DENV-3 in the group of animals labeled us undetermined. As we mentioned previously, these results could be originated by cross reaction or they could represent limited spillback through contact with human environment, but we have to consider that other studies suggest the presence of sylvatic DENV in the Americas [48, 49, 50]. The establishment of a derived sylvatic cycle, as has happened with YFV in the Americas, will hinder the control of DENV in Latin America. Detection of DENV antibodies in black howlers in Northern Argentina underscores the importance of continuing the surveillance of these flaviviruses in non-human primate populations.

Ilheus virus is believed to be maintained in zoonotic cycles between birds and mosquitoes and has been isolated in Central and South America primarily from mosquitoes but also from sentinel monkeys and birds [51]. There are few reports of isolation of ILHV from humans in Central and South America with symptoms ranging from subclinical to severe febrile disease. Mild unspecific symptoms, brief viremia, and lack of laboratory screening techniques in situ are some of the impediments to diagnosis of ILHV infection in disease-endemic areas. The situation is similar for BSQV. We detected low specific prevalences to ILHV and BSQV antibodies, but higher among the animals found positive for an undetermined flavivirus.

Our work evidences circulation of WNV, SLEV, DENV-1, DENV-3, ILHV, and BSQV in wild, non-human primate populations of Corrientes and Chaco provinces, Argentina. Future studies might include ZIKV detection, which has been recognized in South America since 2015. To our knowledge this is the first detection of WNV-specific antibodies in black howlers from Argentina and the first report in free-ranging non-human primates from Latin America. Additionally, our results show that our study population remains susceptible to YFV as no specific neutralizing antibodies were detected. The black howler population remains tentative in the upper Paraná Atlantic Forest. Recurrence of YFV circulation or other pathogens could be detrimental to the population’s existence. Improved monitoring of these agents is needed to evaluate risk to wildlife and human health in the region.